15.10.2021 22:47:45
|
FDA Panel Unanimously Recommends J&J Covid Booster Shot
(RTTNews) - The advisory panel to the U.S. Food and Drug Administration has voted unanimously recommending a booster dose of Johnson & Johnson's (JNJ) vaccine at least two months after people get the first dose.
Johnson & Johnson Friday announced that the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted 19-0 to recommend Emergency Use Authorization for a booster dose of its COVID-19 vaccine for adults aged 18 and older at least two months following initial vaccination with the single-shot vaccine.
The panel's decision was based on by phase 3 findings showing a booster shot increased protection to 94 percent against moderate to severe/critical COVID-19 in the U.S.
"Today's recommendation is based on the totality of evidence, with clinical and real-world data showing that while a single shot offers strong and long-lasting protection against COVID-19, a booster given after the single-dose primary vaccination increases protection, in particular against symptomatic COVID-19," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson.
This same committee on Thursday had recommended Moderna (MRNA) booster shots to people ages 65 and older and other high-risk adults.
Meanwhile, the panel's recommendation is not final and FDA will decide whether to authorize the EUA. However, the FDA usually follows the advice of the committee.
J&J had received authorization for its vaccine in late February. The company had submitted a request to FDA to approve a booster shot of its one-dose vaccine for people ages 18 and older on October 5.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
19.12.24 |
Börse New York in Grün: Anleger lassen Dow Jones zum Start des Donnerstagshandels steigen (finanzen.at) | |
18.12.24 |
Dow Jones-Handel aktuell: Dow Jones letztendlich mit Abgaben (finanzen.at) | |
18.12.24 |
Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Verlust hätte ein Investment in Johnson Johnson von vor einem Jahr eingebracht (finanzen.at) | |
17.12.24 |
Dow Jones-Handel aktuell: Dow Jones legt zum Handelsende den Rückwärtsgang ein (finanzen.at) | |
17.12.24 |
NYSE-Handel Dow Jones am Dienstagnachmittag mit Abgaben (finanzen.at) | |
17.12.24 |
Dow Jones-Handel aktuell: Dow Jones fällt (finanzen.at) | |
16.12.24 |
Schwacher Handel in New York: Dow Jones schlussendlich in Rot (finanzen.at) | |
11.12.24 |
Angespannte Stimmung in New York: Dow Jones beendet die Mittwochssitzung im Minus (finanzen.at) |